Peter Goadsby discusses the rationale for using CGRP antibodies in the treatment of migraine and the study findings so far.
Trending Topic
Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
The prevalence of unruptured intracranial aneurysms (IAs) is approximately 3% of the population, with incidence on the rise due to the increased utilization of neuro-imaging for diverse objectives.1,2 The average risk of rupture for unruptured IA is estimated to vary from 0.3% to exceeding 15% per 5 years.3 Ruptured IA is the primary aetiology of […]
